Nasir Khan

Nasir Khan is an accomplished biotechnology professional with extensive experience in technical operations and business strategy. Currently serving as Executive Director and Head of Technical Operations Strategy and Business Operations at Sarepta Therapeutics since July 2023, Nasir also co-founded AbBC Therapies in March 2014, where efforts focus on developing innovative antibody-drug conjugate therapies. Prior roles include Senior Director positions at Johnson & Johnson, overseeing CMC portfolio delivery optimization and external manufacturing for biotherapeutics, and significant contributions to the nipocalimab program at Momenta Pharmaceuticals. Earlier in the career, Nasir held various director and associate director roles at AVEO Oncology, specializing in CMC strategy and biologics outsourcing. Nasir earned a Bachelor of Science degree in Molecular Genetics from the University of Connecticut.